Denise A Yardley

4PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 08, 2023
Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2- Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7.

Aleix Prat, Nadia Solovieff, Fabrice André

|Jul 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.

Francisco Hermida-Prado, Yingtian Xie, Shira Sherman

|Feb 16, 2020
Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy.

Denise A Yardley, Nancy Peacock, Brooke Daniel

|May 17, 2017
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.

Denise A Yardley, Edward R Arrowsmith, Brooke R Daniel

Pageof 1

Frequent Collaborators

1 joint publications

Francisco Hermida-Prado

1 joint publications

Yingtian Xie

1 joint publications

Shira Sherman

1 joint publications

Zsuzsanna Nagy